Gene therapies hold immense promise for treating sight loss. These therapies use a modified, harmless virus to deliver ...

DELRAY BEACH, FL / ACCESS Newswire / August 12, 2025 / Adolore BioTherapeutics, Inc., ("Company" or "Adolore") announced that ...

A research team headed by the University of Zurich has developed a powerful new method to precisely edit DNA by combining ...

Sartorius Stedim Biotech has agreed to invest $3m in Nanotein Technologies, a US-based company engaged in the development of ...

The use of artificial intelligence for batch monitoring and digital twin development are redefining process control — ...

A research team headed by the University of Zurich has developed a powerful new method to precisely edit DNA by combining ...

A Food and Drug Administration official is getting his job back as the agency’s top vaccine regulator, less than two weeks ...

HIV-fighting antibodies produced in infant macaques in a preclinical trial could be the future of HIV prevention in humans, ...

DELRAY BEACH, FL / ACCESS Newswire / August 12, 2025 / Adolore BioTherapeutics, Inc., ("Company" or "Adolore") announced that Roy Clifford Levitt, MD, Clinical Professor at the University of Miami, Pr ...

Sarepta’s troubles had nothing to do with Arrowhead’s assets, and yet both companies have seen their stock prices decline ...

Surging demand for vectors has also prompted suppliers to explore novel transfection technologies—including electroporation or transposon-based systems—to improve yield. Traditional methods rely on ...

This is the web edition of D.C. Diagnosis, STAT's twice-weekly newsletter about the politics and policy of health and ...